Pancreatic Somatostatinoma Diagnosed Preoperatively: Report of a Case
Abstract
Context Somatostatinoma is a rare neoplasm of the pancreas. Preoperative diagnosis is often difficult. Case report We report a 72-year-old woman with a pancreatic head tumor measuring 37 mm in diameter, and enlargement of the lymph nodes on the anterior surface of the pancreatic head and the posterior surface of the horizontal part of the duodenum. Laboratory data showed an elevated plasma somatostatin concentration. Examination of a biopsy specimen of the pancreatic head mass obtained by endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) showed histopathological features of a neuroendocrine tumor. Immunohistochemical staining showed that the tumor cells were positive for somatostatin, leading to a preoperative diagnosis of pancreatic somatostatinoma. The patient underwent pylorus-preserving pancreaticoduodenectomy. The plasma somatostatin concentration decreased progressively after surgery. Conclusions A rare case of pancreatic somatostatinoma with lymph node metastases was presented. Immunohistochemical analysis of a biopsy specimen obtained by EUS-FNA was useful for preoperative diagnosis.
Image: Location of a pancreatic somatostatinoma and lymph node metastases.
Downloads
References
Nesi G, Marcucci T, Rubio CA, Brandi ML, Tonelli F. Somatostatinoma: clinico-pathological features of three cases and literature reviewed. J Gastroenterol Hepatol 2008; 23:521-6.
Larsson LI, Hirsch MA, Holst JJ, Ingemansson S, Kuhl C, Jensen SL, et al. Pancreatic somatostatinoma. Clinical features and physiological implications. Lancet 1977; 1:666-8.
Zhang B, Xie QP, Gao SL, Fu YB, Wu YL. Pancreatic somatostatinoma with obscure inhibitory syndrome and mixed pathological pattern. J Zhejiang Univ Sci B 2010; 11:22-6.
Cao XP, Liu YY, Xiao HP, Li YB, Wang LT, Xiao P. Pancreatic somatostatinoma characterized by extreme hypoglycemia. Chin Med J (Engl) 2009; 122:1709-12.
Tomono H, Kitamura H, Iwase M, Kuze S, Toyoda F, Mori N, et al. A small, incidentally detected pancreatic somatostatinoma: report of a case. Surg Today 2003; 33:62-5.
Suzuki H, Kuwano H, Masuda N, Hashimoto S, Kanoh K, Nomoto K, et al. Diagnostic usefulness of FDG-PET for malignant somatostatinoma of the pancreas. Hepatogastroenterology 2008; 55:1242-5.
Vilmann P, Saftoiu A, Hollerbach S, Skov BG, Linnemann D, Popescu CF, et al. Multicenter randomized controlled trial comparing the performance of 22 gauge versus 25 gauge EUS-FNA needles in solid masses. Scand J Gastroenterol 2013; 48:877-83.
Dinesh U, Pervatikar SK, Rao R. FNAC diagnosis of pancreatic somatostatinoma. J Cytol 2009; 26:153-5.
Konomi K, Chijiiwa K, Katsuta T, Yamaguchi K. Pancreatic somatostatinoma: a case report and review of the literature. J Surg Oncol 1990; 43:259-65.
Ito T, Igarashi H, Jensen RT. Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances. Best Pract Res Clin Gastroenterol 2012; 26:737-53.
Moertel CG, Lefkopoulo M, Lipsitz S, Hahn RG, Klaassen D. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma. N Engl J Med 1992; 326:519-23.

Copyright (c) 2014 Yasuhisa Mori, Norihiro Sato, Ryuta Taniguchi, Toshihisa Tamura, Noritaka Minagawa, Kazunori Shibao, Aiichiro Higure, Mitsuhiro Nakamoto, Masashi Taguchi, Koji Yamaguchi

This work is licensed under a Creative Commons Attribution 4.0 International License.
As a member of Publisher International Linking Association, PILA, iMedPub Group’s JOP follows the Creative Commons Attribution License and Scholars Open Access publishing policies. Journal of the Pancreas is the Council Contributor Member of Council of Science Editors (CSE) and following the CSE slogan Education, Ethics, and Evidence for Editors.